Visiomed Group SA
Klea Holding SA, together with its subsidiaries, provides healthcare technology and services in France and internationally. It offers BewellConnect, an eco-system of health solutions, including enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; and Smart Salem, a medical fitness screening device. The company … Read more
Visiomed Group SA (VMDGF) - Total Assets
Latest total assets as of June 2024: $36.17 Million USD
Based on the latest financial reports, Visiomed Group SA (VMDGF) holds total assets worth $36.17 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Visiomed Group SA - Total Assets Trend (2019–2023)
This chart illustrates how Visiomed Group SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Visiomed Group SA - Asset Composition Analysis
Current Asset Composition (December 2023)
Visiomed Group SA's total assets of $36.17 Million consist of 14.4% current assets and 85.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.1% |
| Accounts Receivable | $1.18 Million | 3.2% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $356.00K | 1.0% |
| Goodwill | $24.60 Million | 67.2% |
Asset Composition Trend (2019–2023)
This chart illustrates how Visiomed Group SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Visiomed Group SA's current assets represent 14.4% of total assets in 2023, a decrease from 90.1% in 2019.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2023, down from 44.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 67.0% of total assets, an increase from 4.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 67.2% of total assets.
Visiomed Group SA Competitors by Total Assets
Key competitors of Visiomed Group SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
|
Optipharm.CO.LTD
KQ:153710
|
Korea | ₩42.32 Billion |
|
Bionet
TWO:1784
|
Taiwan | NT$3.10 Billion |
Visiomed Group SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Visiomed Group SA generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Visiomed Group SA generates $ 2.46 in net profit.
Visiomed Group SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.60 | 1.19 | 1.17 |
| Quick Ratio | 0.60 | 1.19 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.29 Million | $ 992.00K | $ 1.00 Million |
Visiomed Group SA - Advanced Valuation Insights
This section examines the relationship between Visiomed Group SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.35 |
| Latest Market Cap to Assets Ratio | 2.20 |
| Asset Growth Rate (YoY) | 1.4% |
| Total Assets | $36.60 Million |
| Market Capitalization | $80.39 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Visiomed Group SA's assets at a significant premium ( 2.20x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Visiomed Group SA's assets grew by 1.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Visiomed Group SA (2019–2023)
The table below shows the annual total assets of Visiomed Group SA from 2019 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $36.60 Million | +1.42% |
| 2022-12-31 | $36.09 Million | -18.12% |
| 2021-12-31 | $44.07 Million | +645.79% |
| 2020-12-31 | $5.91 Million | -59.89% |
| 2019-12-31 | $14.73 Million | -- |